PBIL introduces capital connect to bridge sectors and capital
Prime Bank Investment Limited (PBIL), a wholly owned subsidiary of Prime Bank, has launched its flagship initiative, Capital Connect: PBIL–Industry Engagement, with a high-impact debut focused on the health and pharmaceutical sector on May 26, 2025.
In his keynote, Syed M Omar Tayub, Managing Director & CEO of PBIL, stated, `Capital Connect is our signature platform to engage industry leaders, surface actionable insights and unlock capital access to accelerate investment readiness. Our goal is to catalyse the next wave of growth across Bangladesh's emerging sectors.'
Capital Connect is a recurring industry-focused platform designed to accelerate sectoral growth through strategic market mapping, investment readiness enablement, facilitating access to capital, offering guidance on liquidity management and wealth strategy, and driving policy change through evidence-based research, reflecting PBIL's vision to accelerate market preparedness and drive long-term value creation while reinforcing its commitment to broadening #AccessToCapital.
Keep updated, follow The Business Standard's Google news channel
The inaugural session was joined by senior management from over a dozen mostly non-listed emerging pharmaceutical companies. Discussions centred on capital raising instruments, including IPOs, green bonds, Sukuk, private equity (PE), and foreign direct investment (FDI), as well as corporate governance, financial reporting, thematic investing, and regulatory alignment to ease market entry and reduce dependence on conventional bank finance.
This successful launch marks the beginning of a series of Capital Connect engagements across multiple industries, reinforcing PBIL's commitment to bridging market gaps, enabling scalable fundraising, and driving ecosystem-wide collaboration with regulators, development finance institutions (DFIs), sovereign funds, and international investment banks.
